{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:25:09Z","timestamp":1778757909470,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"National Science and Technology Major Project","award":["2014 ZX100002002"],"award-info":[{"award-number":["2014 ZX100002002"]}]},{"name":"Fourth Youth Science Foundation of First Hospital of Jilin University","award":["jdyy20121224"],"award-info":[{"award-number":["jdyy20121224"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.biopha.2018.05.063","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T03:58:58Z","timestamp":1527220738000},"page":"729-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Cripto-1 promotes resistance to drug-induced apoptosis by activating the TAK-1\/NF-\u03baB\/survivin signaling pathway"],"prefix":"10.1016","volume":"104","author":[{"given":"YingYu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XuGuang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhenBo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YuXin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"YingShi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JunQi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2018.05.063_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.24064","article-title":"Tumor resistance to apoptosis","volume":"124","author":"Fulda","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"37","key":"10.1016\/j.biopha.2018.05.063_bib0010","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1038\/sj.onc.1208918","article-title":"Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis","volume":"24","author":"Strizzi","year":"2005","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.biopha.2018.05.063_bib0015","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1517\/13543776.2010.530659","article-title":"Targeting the embryonic gene cripto-1 in cancer and beyond","volume":"20","author":"Bianco","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.063_bib0020","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s13277-014-2695-1","article-title":"Cripto-1 expression and its prognostic value in human bladder cancer patients","volume":"36","author":"Wei","year":"2015","journal-title":"Tumour Biol."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.063_bib0025","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ajpath.2012.02.031","article-title":"Role of cripto-1 during epithelial-to-mesenchymal transition in development and cancer","volume":"180","author":"Rangel","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.063_bib0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2353\/ajpath.2010.100102","article-title":"Role of cripto-1 in stem cell maintenance and malignant progression","volume":"177","author":"Bianco","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"14","key":"10.1016\/j.biopha.2018.05.063_bib0035","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.febslet.2012.01.051","article-title":"Cripto\/GRP78 modulation of the TGF-beta pathway in development and oncogenesis","volume":"586","author":"Gray","year":"2012","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.063_bib0040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2016.03.002","article-title":"Noncanonical NF-kappaB signaling in health and disease","volume":"22","author":"Cildir","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.063_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells5020015","article-title":"Roles of NF-kappaB in cancer and inflammatory diseases and their therapeutic approaches","volume":"5","author":"Park","year":"2016","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2018.05.063_bib0050","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s12032-010-9601-5","article-title":"Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells","volume":"28","author":"Hu","year":"2011","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.063_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/cells5020016","article-title":"The NF-kappaB pathway and cancer stem cells","volume":"5","author":"Rinkenbaugh","year":"2016","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.biopha.2018.05.063_bib0060","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1007\/s13277-015-3575-z","article-title":"MST-312 induces G2\/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-kappaB pathway","volume":"36","author":"Fatemi","year":"2015","journal-title":"Tumour Biol."},{"issue":"July (13)","key":"10.1016\/j.biopha.2018.05.063_bib0065","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1128\/MCB.22.13.4439-4449.2002","article-title":"Dual roles of cripto as a ligand and coreceptor in the nodal signaling pathway","volume":"22","author":"Yan","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"December","key":"10.1016\/j.biopha.2018.05.063_bib0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semcancer.2014.08.003","article-title":"The multifaceted role of the embryonic gene cripto-1 in cancer, stem cells and epithelial-mesenchymal transition","volume":"29","author":"Klauzinska","year":"2014","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.063_bib0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/BJ20101780","article-title":"Testes-specific protease 50 (TSP50) promotes cell proliferation through the activation of the nuclear factor kappaB (NF-kappaB) signalling pathway","volume":"436","author":"Song","year":"2011","journal-title":"Biochem. J."},{"issue":"June (6)","key":"10.1016\/j.biopha.2018.05.063_bib0080","volume":"71","author":"Sung","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"July (4)","key":"10.1016\/j.biopha.2018.05.063_bib0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jcb.20080","article-title":"Blocking anti-apoptosis as a strategy for cancer chemotherapy: NF-kappaB as a target","volume":"92","author":"Monks","year":"2004","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.063_bib0090","doi-asserted-by":"crossref","first-page":"e1005648","DOI":"10.1371\/journal.ppat.1005648","article-title":"An oncogenic virus promotes cell survival and cellular transformation by suppressing glycolysis","volume":"12","author":"Zhu","year":"2016","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.063_bib0095","doi-asserted-by":"crossref","first-page":"746","DOI":"10.7150\/jca.13289","article-title":"Silencing of hERG1 Gene inhibits proliferation and invasion, and induces apoptosis in human osteosarcoma cells by targeting the NF-kappaB pathway","volume":"7","author":"Zeng","year":"2016","journal-title":"J. Cancer"},{"issue":"June (16)","key":"10.1016\/j.biopha.2018.05.063_bib0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","article-title":"Survivin: a unique target for tumor therapy","volume":"23","author":"Garg","year":"2016","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.063_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2044-5040-2-3","article-title":"TAK-1\/p38\/nNFkappaB signaling inhibits myoblast differentiation by increasing levels of Activin A","volume":"2","author":"Trendelenburg","year":"2012","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.biopha.2018.05.063_bib0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-4690-11-45","article-title":"HIV-1 Vpr stimulates NF-kappaB and AP-1 signaling by activating TAK1","volume":"11","author":"Liu","year":"2014","journal-title":"Retrovirology"},{"issue":"4","key":"10.1016\/j.biopha.2018.05.063_bib0115","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cell.2011.12.033","article-title":"TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers","volume":"148","author":"Singh","year":"2012","journal-title":"Cell"},{"issue":"December","key":"10.1016\/j.biopha.2018.05.063_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semcancer.2014.08.003","article-title":"The multifaceted role of the embryonic gene cripto-1 in cancer, stem cells and epithelial-mesenchymal transition","volume":"29","author":"Klauzinska","year":"2014","journal-title":"Semin Cancer Biol."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.063_bib0125","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/labinvest.2011.90","article-title":"Interferon consensus sequence binding protein-induced cell proliferation is mediated by TGF-beta signaling and p38 MAPK activation","volume":"91","author":"Sung","year":"2011","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.063_bib0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12026-015-8724-3","article-title":"Cripto-1 modulates macrophage cytokine secretion and phagocytic activity via NF-kappaB signaling","volume":"64","author":"Zhang","year":"2016","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.063_bib0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1087057111398486","article-title":"Alantolactone inhibits cell proliferation by interrupting the interaction between cripto-1 and activin receptor type II A in activin signaling pathway","volume":"16","author":"Shi","year":"2011","journal-title":"J. Biomol. Screen"},{"issue":"May (5)","key":"10.1016\/j.biopha.2018.05.063_bib0140","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3892\/or.2015.3847","article-title":"LMP-1 induces survivin expression to inhibit cell apoptosis through the NF-\u03baB and PI3K\/Akt signaling pathways in nasal NK\/T-cell lymphoma","volume":"33","author":"Sun","year":"2015","journal-title":"Oncol. Rep."},{"issue":"June (6)","key":"10.1016\/j.biopha.2018.05.063_bib0145","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.3892\/mmr.2016.5126","article-title":"MicroRNA-15b suppresses the growth and invasion of glioma cells through targeted inhibition of cripto-1 expression","volume":"13","author":"Sun","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2018.05.063_bib0150","first-page":"1","article-title":"Saikosaponin A, an active glycoside from radix bupleuri, reverses P-glycoprotein-mediated multidrug resistance in MCF-7\/ADR cells and HepG2\/ADM cells","author":"Ye","year":"2016","journal-title":"Xenobiotica"},{"issue":"18","key":"10.1016\/j.biopha.2018.05.063_bib0155","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.4161\/cc.26034","article-title":"TGF-beta: an emerging player in drug resistance","volume":"12","author":"Brunen","year":"2013","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.biopha.2018.05.063_bib0160","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1172\/JCI73048","article-title":"CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance","volume":"124","author":"Park","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.063_bib0165","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0962-8924(01)02130-4","article-title":"TGF-beta signaling in cancer--a double-edged sword","volume":"11","author":"Akhurst","year":"2001","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biopha.2018.05.063_bib0170","doi-asserted-by":"crossref","DOI":"10.1111\/imm.12617","article-title":"Lipid rafts in immune signaling: current progress and future perspective","author":"Varshney","year":"2016","journal-title":"Immunology"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217356317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217356317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:31:51Z","timestamp":1760095911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217356317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":34,"alternative-id":["S0753332217356317"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.063","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cripto-1 promotes resistance to drug-induced apoptosis by activating the TAK-1\/NF-\u03baB\/survivin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}